Biosecurity Organizations (Overview)

Overview

The biosecurity organizational landscape relevant to AI-era risks spans established institutions with decades of policy influence, EA-funded startups building novel technical infrastructure, and traditional international partnerships operating at billion-dollar scale. These organizations collectively address the growing convergence of AI capabilities and biological risks through approaches ranging from DNA synthesis screening to pathogen surveillance to vaccine development.

The funding landscape is heavily shaped by Coefficient GivingOrganizationCoefficient GivingCoefficient Giving (formerly Open Philanthropy) has directed \$4B+ in grants since 2014, including \$336M to AI safety (~60% of external funding). The organization spent ~\$50M on AI safety in 2024...Quality: 55/100, which has directed over $90M to organizations in this set. Outside EA, CEPIOrganizationCoalition for Epidemic Preparedness InnovationsCEPI is an international vaccine development partnership founded in 2017 that addresses market failures in pandemic preparedness by funding vaccines for diseases with limited commercial viability. ...Quality: 53/100 operates at a fundamentally different scale ($760M+ raised, $3.5B five-year plan) but focuses primarily on natural pandemic threats rather than deliberate misuse.

Identity and Approach

Approach uses SecureBioOrganizationSecureBioA biosecurity nonprofit applying the Delay/Detect/Defend framework to protect against catastrophic pandemics, including AI-enabled biological threats, through wastewater surveillance (Nucleic Acid ...Quality: 65/100's Delay/Detect/Defend framework plus Governance. Threat Focus distinguishes natural pandemics, deliberate/engineered threats, and AI-enabled biological risks.

Funding and Assessment

EA Funding includes Coefficient Giving, Founders Pledge, Survival and Flourishing Fund, EA Infrastructure Fund, and Emergent Ventures. Impact reflects demonstrated achievements to date. Promise reflects potential given positioning, approach, and resources. Both use A (highest) through F (lowest).

Rating Rationale

• A/A- impact: JHU CHS (25+ years of policy influence, Event 201, WHO Collaborating Centre), CEPI (8 authorized COVID vaccines, est. 2.7M deaths averted), NTI | bio (spawned IBBIS, GHS Index, Bio Funders Compact)
• B+/B impact: SecureBio (VCT adopted by major AI labs, NAO monitoring 31 sites), SecureDNA (deployed cryptographic screening exceeding US requirements), CLTR (documented UK policy wins on small budget)
• C+/C impact: Blueprint (impressive research output but young), IBBIS (Common Mechanism deployed but only 15% provider adoption), 1Day Sooner (UK challenge trial success, broad portfolio), CSR (traditional think tank, biosecurity not primary focus)
• D impact: Red Queen Bio (launched Nov 2025, no demonstrated output yet)
• A- promise: SecureBio (unique position at AI-bio intersection, VCT becoming industry standard)
• B+ promise: JHU CHS, NTI | bio, SecureDNA, CLTR, Blueprint (each has strong positioning with different risk profiles)
• B promise: CEPI (mature but structural tensions on equity), IBBIS (addresses critical gap), Red Queen Bio (novel thesis, OpenAI backing, but unproven)

Coefficient Giving Concentration

Coefficient GivingOrganizationCoefficient GivingCoefficient Giving (formerly Open Philanthropy) has directed \$4B+ in grants since 2014, including \$336M to AI safety (~60% of external funding). The organization spent ~\$50M on AI safety in 2024...Quality: 55/100 is the dominant funder in EA-aligned biosecurity. Six of the eleven organizations receive OP funding, and for several it constitutes the majority of their budget:

This concentration creates both strength (coordinated strategy) and risk (single point of funding failure). SecureBio derives nearly 100% of identified funding from Coefficient Giving.

Two organizations operate entirely outside the EA funding ecosystem:

• CEPI: $760M+ from governments and traditional philanthropy. Dwarfs all EA biosecurity funding combined.
• Red Queen Bio: $15M seed round led by OpenAIOrganizationOpenAIComprehensive organizational profile of OpenAI documenting evolution from 2015 non-profit to Public Benefit Corporation, with detailed analysis of governance crisis, 2024-2025 ownership restructuri...Quality: 62/100 — the first major AI lab direct investment in biosecurity infrastructure.

Notable Patterns

Synthesis screening convergence: Three organizations work on DNA synthesis screening with complementary approaches — SecureDNAOrganizationSecureDNAA Swiss nonprofit foundation providing free, privacy-preserving DNA synthesis screening software using novel cryptographic protocols. Co-founded by Kevin Esvelt and Turing Award winner Andrew Yao, ...Quality: 60/100 (cryptographic privacy-preserving tool), IBBISOrganizationIBBIS (International Biosecurity and Biosafety Initiative for Science)An independent Swiss foundation launched in February 2024, spun out of NTI | bio, that develops free open-source tools for DNA synthesis screening and works to strengthen international biosecurity ...Quality: 60/100 (open-source Common Mechanism + international standards), and NTI | bioOrganizationNTI | bio (Nuclear Threat Initiative - Biological Program)The biosecurity division of the Nuclear Threat Initiative, NTI | bio works to reduce global catastrophic biological risks through DNA synthesis screening, BWC strengthening, the Global Health Secur...Quality: 60/100 (governance advocacy). IBBIS was originally incubated within NTI | bio.

AI lab engagement: The biosecurity field is seeing growing direct engagement from AI labs. OpenAIOrganizationOpenAIComprehensive organizational profile of OpenAI documenting evolution from 2015 non-profit to Public Benefit Corporation, with detailed analysis of governance crisis, 2024-2025 ownership restructuri...Quality: 62/100 led Red Queen Bio's $15M seed round. SecureBioOrganizationSecureBioA biosecurity nonprofit applying the Delay/Detect/Defend framework to protect against catastrophic pandemics, including AI-enabled biological threats, through wastewater surveillance (Nucleic Acid ...Quality: 65/100's VCT is used by major AI labs for pre-release safety evaluations. JHU CHSOrganizationJohns Hopkins Center for Health SecurityThe Johns Hopkins Center for Health Security is a well-established biosecurity organization that has significantly influenced US policy on pandemic preparedness and biological threats, with recent ...Quality: 63/100 has convened meetings with OpenAI, AnthropicOrganizationAnthropicComprehensive reference page on Anthropic covering financials (\$380B valuation, \$19B ARR), safety research (Constitutional AI, mechanistic interpretability, model welfare), governance (LTBT struc...Quality: 74/100, DeepMind, and others on AIxBio risks.

Age vs. demonstrated impact: The oldest organization (JHU CHS, 1998) has the clearest demonstrated impact, while the newest (Red Queen Bio, 2025) has the most novel thesis but no output yet. This expected pattern makes "promise" ratings more speculative for newer organizations.

Far-UVC convergence: Both Blueprint BiosecurityOrganizationBlueprint BiosecurityAn EA-funded biosecurity nonprofit founded in 2023 by Jake Swett, dedicated to achieving breakthroughs in pandemic prevention through far-UVC germicidal light, next-generation PPE, and glycol vapor...Quality: 60/100 and 1Day SoonerOrganization1Day SoonerA pandemic preparedness nonprofit originally founded to advocate for COVID-19 human challenge trials, now working on indoor air quality (germicidal UV), advance market commitments for vaccines, hep...Quality: 60/100 work on far-UVC/indoor air quality from different angles — Blueprint through comprehensive research and deployment blueprints, 1Day Sooner through policy advocacy and cost-effectiveness analysis with Rethink Priorities.

Key Uncertainties